However, genetic alterations in LRIG1, such as copy number variation, are observed in less than 1% of breast cancers (Supplemental Fig. 5), indicating that epigenetic silencing is a dominant mechanism of LRIG1 loss. This evidence concerns the gene LRIG1 and breast carcinoma.